Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucose

被引:22
作者
Hwang, You-Cheol [1 ]
Ahn, Hong-Yup [2 ]
Park, Sung-Woo [3 ]
Park, Cheol-Young [3 ]
机构
[1] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Div Endocrinol & Metab, Dept Med,Sch Med, Seoul, South Korea
[2] Dongguk Univ Seoul, Dept Stat, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Endocrinol & Metab, Seoul 110746, South Korea
关键词
HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; CHOLESTEROL LEVELS; MALE PARTICIPANTS; MELLITUS; SUBPOPULATIONS; METABOLISM; PARTICLES;
D O I
10.1530/EJE-14-0195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: HDLs have many diverse functions. The goal of this study was to determine the association of HDL cholesterol (HDL-C) and apolipoprotein A-I (apoA-I) with the development of type 2 diabetes (T2D). In particular, this study determined the association between the ratio of HDL-C to apoA-I (HA) and incident T2D. Design and methods: A total of 27 988 subjects with impaired fasting glucose (IFG) (18 266 men and 9722 women) aged 21-91 years (mean age 40.7 years) were followed for a mean duration of 2.81 years. Results: Study subjects were divided into quartiles according to the baseline HA ratio. Age, male sex, current smoking, BMI, waist circumference, and high-sensitivity C-reactive protein decreased across the quartiles, and all metabolic profiles, including blood pressure, fasting glucose, insulin resistance as determined by homeostasis model assessment of insulin resistance, and lipid measurements such as total cholesterol, LDL cholesterol, non-HDL-C, and apoB, improved as the HA ratio increased. In addition, incident cases of T2D decreased as the HA ratio increased, independent of age, sex, BMI, current smoking, systolic blood pressure, HbA1c, fasting serum insulin, family history of diabetes, and serum triglyceride concentrations (HR (95% CI) of fourth quartile vs first quartile; 0.76 (0.67-0.86), P < 0.0001). Conclusions: A higher HA ratio was associated with favorable metabolic profiles and a lower risk of T2D development in subjects with IFG.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 26 条
  • [2] Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment
    Ansell, BJ
    Navab, M
    Hama, S
    Kamranpour, N
    Fonarow, G
    Hough, G
    Rahmani, S
    Mottahedeh, R
    Dave, R
    Reddy, ST
    Fogelman, AM
    [J]. CIRCULATION, 2003, 108 (22) : 2751 - 2756
  • [3] High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study
    Asztalos, BF
    Cupples, LA
    Demissie, S
    Horvath, KV
    Cox, CE
    Batista, MC
    Schaefer, EJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) : 2181 - 2187
  • [4] High-density lipoprotein subpopulations in pathologic conditions
    Asztalos, BF
    Schaefer, EJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (7A) : 12E - 17E
  • [5] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [6] The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes
    Barter, Philip J.
    [J]. DIABETES & METABOLISM JOURNAL, 2011, 35 (02) : 101 - 106
  • [7] Biological activities of HDL subpopulations and their relevance to cardiovascular disease
    Camont, Laurent
    Chapman, M. John
    Kontush, Anatol
    [J]. TRENDS IN MOLECULAR MEDICINE, 2011, 17 (10) : 594 - 603
  • [8] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY
    CASTELLI, WP
    GARRISON, RJ
    WILSON, PWF
    ABBOTT, RD
    KALOUSDIAN, S
    KANNEL, WB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20): : 2835 - 2838
  • [9] High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
    Drew, Brian G.
    Duffy, Stephen J.
    Formosa, Melissa F.
    Natoli, Alaina K.
    Henstridge, Darren C.
    Penfold, Sally A.
    Thomas, Walter G.
    Mukhamedova, Nigora
    de Courten, Barbora
    Forbes, Josephine M.
    Yap, Felicia Y.
    Kaye, David M.
    van Hall, Gerrit
    Febbraio, Mark A.
    Kemp, Bruce E.
    Sviridov, Dmitri
    Steinberg, Gregory R.
    Kingwell, Bronwyn A.
    [J]. CIRCULATION, 2009, 119 (15) : 2103 - U134
  • [10] Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome
    Garin, MCB
    Kalix, B
    Morabia, A
    James, RW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) : 2264 - 2269